| Postpartum Depression |
1 |
1 |
| Depression |
0 |
0.95 |
| Pregnancy |
0 |
0.92 |
| Postpartum |
0 |
0.72 |
| Major Depression |
0 |
0.51 |
| Bipolar Disorder |
0 |
0.42 |
| Anxiety |
0 |
0.29 |
| Anxiety Disorder |
0 |
0.29 |
| Adverse Effects |
0 |
0.24 |
| Antidepressant drug |
0 |
0.24 |
| Generalized Anxiety Disorder |
0 |
0.24 |
| Otolaryngology |
0 |
0.24 |
| Patient Safety |
0 |
0.21 |
| Gamma aminobutyric acid |
0 |
0.19 |
| Impairment |
0 |
0.19 |
| North Carolina |
0 |
0.19 |
| Liver Disease |
0 |
0.17 |
| Receptors |
0 |
0.14 |
| Sedative |
0 |
0.14 |
| Sterilization, Birth Control |
0 |
0.14 |
| ADHD |
0 |
0.13 |
| Benzodiazepines |
0 |
0.1 |
| Birth |
0 |
0.1 |
| Brain |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Fellowship |
0 |
0.1 |
| Insomnia |
0 |
0.1 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.1 |
| Sleep Disorders |
0 |
0.1 |
| Steroids |
0 |
0.1 |
| Suicide |
0 |
0.1 |
| Contraception |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Premenstrual Dysphoric Disorder |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.06 |